310 related articles for article (PubMed ID: 9674936)
21. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
Einat H; Chen G; Manji H
Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
[TBL] [Abstract][Full Text] [Related]
22. Inositol, lithium, and the brain.
Agranoff BW; Fisher SK
Psychopharmacol Bull; 2001; 35(3):5-18. PubMed ID: 12397875
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells.
Seelan RS; Khalyfa A; Lakshmanan J; Casanova MF; Parthasarathy RN
Neuroscience; 2008 Feb; 151(4):1184-97. PubMed ID: 18222042
[TBL] [Abstract][Full Text] [Related]
24. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder.
Fatemi SH; Reutiman TJ; Folsom TD
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1090-5. PubMed ID: 19754458
[TBL] [Abstract][Full Text] [Related]
25. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
[TBL] [Abstract][Full Text] [Related]
26. Lithium therapy for mania and depression.
Murray JB
J Gen Psychol; 1985 Jan; 112(1):5-33. PubMed ID: 2860201
[TBL] [Abstract][Full Text] [Related]
27. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
[TBL] [Abstract][Full Text] [Related]
28. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.
Moore GJ; Bebchuk JM; Parrish JK; Faulk MW; Arfken CL; Strahl-Bevacqua J; Manji HK
Am J Psychiatry; 1999 Dec; 156(12):1902-8. PubMed ID: 10588403
[TBL] [Abstract][Full Text] [Related]
29. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
[TBL] [Abstract][Full Text] [Related]
30. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of lithium in mania and maintenance therapy of bipolar disorder.
Bowden CL
J Clin Psychiatry; 2000; 61 Suppl 9():35-40. PubMed ID: 10826659
[TBL] [Abstract][Full Text] [Related]
32. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications.
Post RM
J Psychiatr Res; 2007 Dec; 41(12):979-90. PubMed ID: 17239400
[TBL] [Abstract][Full Text] [Related]
33. Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness.
McNamara RK; Ostrander M; Abplanalp W; Richtand NM; Benoit SC; Clegg DJ
Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):237-57. PubMed ID: 16935483
[TBL] [Abstract][Full Text] [Related]
34. Bipolar disorder: are there manic-prone and depressive-prone forms?
Quitkin FM; Rabkin JG; Prien RF
J Clin Psychopharmacol; 1986 Jun; 6(3):167-72. PubMed ID: 3711367
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of PKC alpha by lithium in vitro.
Bitran JA; Manji HK; Potter WZ; Gusovsky F
Psychopharmacol Bull; 1995; 31(2):449-52. PubMed ID: 7491404
[TBL] [Abstract][Full Text] [Related]
36. Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex.
Brandish PE; Su M; Holder DJ; Hodor P; Szumiloski J; Kleinhanz RR; Forbes JE; McWhorter ME; Duenwald SJ; Parrish ML; Na S; Liu Y; Phillips RL; Renger JJ; Sankaranarayanan S; Simon AJ; Scolnick EM
Neuron; 2005 Mar; 45(6):861-72. PubMed ID: 15797548
[TBL] [Abstract][Full Text] [Related]
37. Lithium in the long-term treatment of bipolar disorders.
Kleindienst N; Greil W
Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
[TBL] [Abstract][Full Text] [Related]
38. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
Goodwin FK
J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
[TBL] [Abstract][Full Text] [Related]
39. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
[TBL] [Abstract][Full Text] [Related]
40. How can the mood stabilizer VPA limit both mania and depression?
Cheng L; Lumb M; Polgár L; Mudge AW
Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
